Experience

Edward Dyson

    • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 


    • RenalytixAI – £22 Million IPO 


    • Endava – $146 Million IPO 


    • Autolus – $173 Million IPO 


    • Autolus – $173 Million IPO